6505--Intent to Sole Source Transfusion Services and Blood Products FARGO VA Health Care System
ID: 36C26325Q0690Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

NAICS

Blood and Organ Banks (621991)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/7e9b45f89ea4466799bc7cbf64bf5440/view
Timeline
    Description

    The Department of Veterans Affairs, specifically the Fargo VA Health Care System, intends to establish a Sole Source contract for Transfusion Services and Blood Products, focusing on a single supplier within a 30-mile radius to ensure timely delivery. The contract, which will span from October 1, 2025, to September 30, 2030, includes a base year and four one-year options, requiring the contractor to provide blood components that meet FDA and AABB standards, along with reference testing services and emergency support. This procurement is critical for maintaining the health and safety of veterans, ensuring that blood products are readily available and compliant with stringent regulations. Interested parties must submit their responses by May 13, 2025, to Alberta Mickells at Alberta.Mickells@va.gov, as the government will proceed with a sole source acquisition if no competitive responses are received.

    Point(s) of Contact
    Alberta MickellsContract Specialist
    (402) 995-3081
    Alberta.Mickells@va.gov
    Files
    Title
    Posted
    36C26325Q0690_1.docx
    The Fargo VA Health Care System intends to establish a Sole Source contract for Transfusion Services and Blood Products, with a focus on negotiating with a single supplier within a 30-mile radius. This contract, set to run from October 1, 2025, to September 30, 2030, includes a base year and four one-year options. The contractor will provide blood components that comply with FDA and AABB standards, ensuring immediate availability for emergencies, inclusive of after-hours support. Key requirements outline the contractor's responsibilities, including compliance with safety regulations, provision of reference testing services, and management of blood supply logistics. The contractor must maintain accreditation and adhere to strict delivery schedules, categorized as routine, ASAP, or STAT, to meet the medical needs of the facility. Responses to the notice are sought to gauge interest in competitive procurement; however, if none are received, the government will proceed with the sole source acquisition. The notice emphasizes the government’s awareness of the inherent risks associated with blood products and the requirement for comprehensive responses from interested parties, including their capabilities and business classifications. The intent is to ensure optimal quality and reliability in the necessary transfusion services for veterans' healthcare.
    Similar Opportunities
    6505--Whole Blood and Related Blood Products for Veterans Integrated Service Network 8 (VISN 8) facilities
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8 (VISN 8), is seeking qualified contractors to provide whole blood and related blood products for its facilities in Florida. The procurement requires that the products and services be delivered by FDA-registered or licensed blood bank entities that are also accredited by recognized organizations such as AABB, CAP, or the Joint Commission. These blood products are critical for ensuring patient safety and compatibility with their medical conditions. Interested parties must respond to the solicitation, identified as number 36C24826R0013, by January 12, 2026, at 11:00 AM Eastern Time, and can direct inquiries to Contracting Officer Kurt J Kramer at Kurt.Kramer@va.gov or by phone at 407-840-9048.
    RFI for Blood Bank Validation Services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking contractors to provide Blood Bank Validation Services as part of its Electronic Health Record Modernization Integration Office (EHRM-IO) initiative. The primary objective is to validate the Oracle Health Millennium EHR system for 129 blood bank sites across 170 Medical Centers, ensuring compliance with regulatory and accreditation requirements from organizations such as the FDA and AABB. These validation services are critical for ensuring patient and blood product safety, with project management and execution expected to begin by August 1, 2026, and to be completed one month prior to each of the 28 scheduled go-live events between January 2027 and November 2031. Interested parties should submit their capability statements and any questions regarding the Draft Performance Work Statement (PWS) to Steven Baum at steven.baum@va.gov and Wendella Baptiste at wendella.baptiste@va.gov by 5 PM ET on December 18, 2025.
    Q523--Brand Name or Equal to the American Red Cross - Autologous Transfusion Cell Saver. POP: 03/26/2026 thru 03/25/2027. Unrestricted procurement.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Autologous Transfusion Cell Saver Services for the Wilmington VA Medical Center, with a contract period from March 26, 2026, to March 25, 2027. The contractor will be responsible for providing qualified technicians, Cell Saver equipment, and necessary disposables to support Veteran patients in the Operating Room, ensuring compliance with AABB, CAP, and Joint Commission standards, as well as HIPAA regulations. This service is critical for enhancing patient care during surgical procedures by enabling the collection and reinfusion of a patient's own blood, thereby minimizing the need for donor blood. Interested parties should contact Contracting Officer David M Santiago at david.santiago2@va.gov for further details regarding the solicitation.
    6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Hemochron Signature Elite Reagents, with a contract term of one base year and four option years, to support the Southern Arizona Healthcare System in Tucson, Arizona. The procurement includes a variety of specialized medical testing supplies essential for blood coagulation testing, with specific brand-name products required, as detailed in the attached documents. Timely delivery and compliance with FDA standards are critical, as these reagents will be used for patient testing in a healthcare setting. Interested vendors must submit their quotations by December 9, 2025, at 12 PM Pacific Time, and can direct inquiries to Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov.
    Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking a qualified contractor for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on the distribution of BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contractor will be responsible for supplying FDA-approved equipment, reagents, controls, calibrators, and all necessary consumables, along with installation, validation, technical support, preventative maintenance, and staff training, ensuring compliance with specific performance requirements such as rapid analysis and automated calibration. This procurement is critical for enhancing patient care through immunoassays that diagnose various health conditions, including infectious diseases and autoimmune disorders. Quotes are due by December 19, 2025, at 17:00 Pacific Time, and interested parties can contact Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632 for further information.
    6505--Notice of Intent to Award a Sole Source Procurement - Xofigo Radium-223 dichloride
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to Cardinal Health for the procurement of 660 units of XOFIGO® (Radium-223 dichloride). This procurement is based on a letter from Bayer Healthcare, which designates Cardinal Health as the sole distributor of XOFIGO® in the United States, highlighting the critical nature of this pharmaceutical in treating specific medical conditions. Interested parties may submit capability statements or proposals within seven days of the notice's publication, with the deadline set for December 19, 2025; otherwise, the contract will be awarded to Cardinal Health without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    6630--VISN 15 Automated Erythrocyte Sedimentation Rate Analyzers 36C255-26-AP-0538
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for an unrestricted solicitation for Cost-Per-Test (CPT) Blanket Purchase Agreements for Automated Erythrocyte Sedimentation Rate Analyzers intended for the VISN 15 Heartland Network Veterans Affairs Medical Centers (VAMCs). This procurement aims to enhance laboratory capabilities by providing essential equipment for conducting erythrocyte sedimentation rate tests, which are critical for diagnosing various medical conditions. The solicitation is expected to be released around December 19, 2026, with a response deadline set for January 12, 2026, at 10:00 AM Central Time. Interested parties can reach out to Contract Specialist Erika Kobulnicky at Erika.Kobulnicky@va.gov or by phone at 913-946-1991 for further information.
    Blood Bank Analyzer and Reagents
    Dept Of Defense
    The Department of Defense, specifically the Department of the Air Force, is awarding a sole source contract for a Blood Bank Analyzer and associated reagents to be utilized at the David Grant Medical Center located at Travis Air Force Base, California. This procurement is essential for medical laboratory testing, ensuring the facility has the necessary equipment to support blood bank operations. The contract will be managed by the 60th Contracting Squadron, with the primary contacts being Erika Scofield and Roberto Escobedo, who can be reached via email or phone for further inquiries. Interested parties should note that the justification for this sole source award is attached for review.
    Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.